Today's Small Cap Stocks Pulse
Deep Fission targets up to $1.66B valuation in new Nasdaq IPO
Deep Fission announced a Nasdaq IPO seeking $157 million at $24‑$26 per share, which would value the nuclear startup at up to $1.66 billion. The company previously completed a reverse merger that raised $30 million but never traded on the OTCQB. Its latest S‑1 filing shows a cash deficit of $88.1 million as of March, up from $56.2 million in December.
ProPetro COO Adam Muñoz Tackles Cost Cuts as Q1 Revenue Falls 7%
ProPetro (PUMP) posted first‑quarter 2026 revenue of $271 million, a 7% sequential decline, and a net loss of $4 million. COO Adam Muñoz detailed a multi‑pronged effort to tighten the cost structure, accelerate fleet utilization and fund a $540‑$610 million capital program, especially for the PROPWER power‑generation segment.
Park Hotels & Resorts Posts $11 M Q1 Profit, Core RevPAR Up 5% YoY
Park Hotels & Resorts announced a $11 million net income for Q1 2026, driven by more than 5% year‑over‑year growth in core RevPAR. The REIT also sold two non‑core hotels for $31 million and invested $83 million in capital improvements, underscoring its focus...
Nutex Health Q1 Profit Jumps 120% to $46.8M on Rising Demand for Digital Health Services
Nutex Health, Inc. posted a first‑quarter profit of $46.81 million, more than double the $21.22 million earned a year earlier, while revenue rose 2.2% to $216.49 million. The results underscore accelerating demand for the company’s biotech‑adjacent digital health platform.
Alpine Banks of Colorado Announces Financial Results for First Quarter 2026
Alpine Banks of Colorado posted unaudited Q1 2026 results showing net income of $20.2 million, up from $14.3 million a year earlier, and basic earnings per share of $1.26. Net interest margin improved to 3.72% on a tax‑equivalent basis, while total assets reached...
TeraWulf's Real Revenue Driver: AI, Not Bitcoin Mining
Day 17 of 30: How $WULF TeraWulf actually makes money Most people think it's a Bitcoin miner Bitcoin mining was the original business. The bigger one now is AI Here's the real breakdown 🧵👇
TMDX’s OCS Tech Drives Rapid Adoption, Pressures Valuation
$TMDX reports Tuesday after the close This is the only company on earth that keeps a donor heart, lung, or liver beating outside the body Not a metaphor... the organ stays warm and oxygenated e2e The number to watch on Tuesday isn't rev,...
Alerus Q1 2026 Earnings Highlight Retirement Services Growth Amid Deposit Outflow Pressure
Alerus Financial reported $23 million net income for Q1 2026, with retirement and benefit services revenue climbing to $17.4 million despite a 5.9% dip in assets under administration. CFO Alan Villalon cautioned that seasonal deposit outflows could strain the bank’s low‑cost funding...
Shield Therapeutics Posts $2.5M EBIT in Q1, CFO Resigns Amid 11% Share Drop
Shield Therapeutics plc posted a $2.5 million EBIT for the first quarter, a swing from a $4.4 million loss a year earlier, thanks to a $7.9 million development milestone from ASK in China and a 54% jump in ACCRUFeR sales. At the same...
IRhythm Q1 Revenue Jumps 25.7% to $199.4M as Wearable ECG Demand Holds Strong
iRhythm posted $199.4 million in first‑quarter revenue, up 25.7% year‑over‑year, as demand for its wearable ECG platform stays robust. The company narrowed its GAAP net loss to $13.9 million but flagged ongoing regulatory scrutiny, including an FDA warning letter and a pending...
Pacira Q1 2026 Earnings Highlight COO Brendan Teehan's Product Launch Drive
Pacira BioSciences posted a 7% rise in EXPAREL sales to $143.3 M and double‑digit growth for ZILRETTA and ioverao in Q1 2026, attributing the momentum to COO Brendan P. Teehan’s accelerated product launches and expanded sales teams. The company also repurchased...
Vanguard Russell 2000 ETF Posts 11.1% YTD Gain, Beats S&P 500, Nasdaq‑100 and Dow
Vanguard's Russell 2000 ETF (VTWO) logged an 11.1% year‑to‑date return through March 2026, eclipsing the modest 1.6%‑7.1% gains of the S&P 500, Nasdaq‑100 and Dow Jones. The outperformance stems from diversified small‑cap exposure and favorable U.S. policy tailwinds, while larger‑cap indexes remain...
Riot Platforms Posts $167M Revenue but $500M Loss as Bitcoin Mining Scales Up
Riot Platforms posted $167 million in Q1 2026 revenue but a $500 million GAAP loss, driven by non‑cash Bitcoin mark‑to‑market losses. The miner expanded its hash rate to 42.5 exahash, mined 1,473 BTC and secured a 25 MW AMD data‑center lease, yet its shares...
SoFi Posts Record Growth, yet Shares Tumble 15%
$SOFI just printed the cleanest fintech beat I've seen in years Net revenue up 43%, hit 1.1B for the first time Net income 167M EBITDA up 62% 18 straight Rule of 40 quarters Stock dropped 15% the same day Why? Two reasons that are actually fair...
Glen Burnie Bancorp Reports 2026 First Quarter Results
Glen Burnie Bancorp posted a net income of $84 thousand in Q1 2026, reversing a $95 thousand loss in the prior quarter and delivering $0.03 earnings per diluted share. Loans expanded 4.9% quarter‑over‑quarter to $242.6 million, while deposits grew 7.6% to $357.5 million, boosting...
Security Federal Corporation Announces Increase in First Quarter Earnings
Security Federal Corporation reported first‑quarter 2026 net income of $3.1 million, or $1.00 per share, marking a 19.6% increase over the same period last year. The gain was driven by a 9.4% rise in net interest income and a 19.7% jump...
St. Joe Company Posts Record Q1 Hospitality Revenue, Expands Florida Land Portfolio
The St. Joe Company posted $99.1 million in first‑quarter revenue, a 5% rise, driven by a record $44.7 million hospitality haul. While real‑estate revenue grew modestly, leasing fell 10% after the Watercrest senior‑living sale, and the firm secured a 2,653‑homesite DSAP contract with...
Cerus Names Vivek K. Jayaraman as New COO, Raises 2026 Revenue Guidance
Cerus Corporation introduced Vivek K. Jayaraman as its incoming chief operating officer during its Q1 2026 earnings call. The leadership change coincides with a 24% jump in product revenue to $53.7 million and an upward revision of full‑year product revenue guidance...
Summit Slips on Ivonescimab's Apparent Interim Miss in Sign of Investor Frustration
Summit Therapeutics’ shares plunged almost 20% after an interim analysis of its Phase 3 trial of ivonescimab showed a statistical shortfall in a key efficacy endpoint. The miss was limited to a subgroup analysis, but investors interpreted it as a signal...
Getein Biotech Q1 Profit Rises 18% to $10.7M as Revenue Hits $37.5M
Getein Biotech posted a first‑quarter profit of RMB76.3 million ($10.7 M), up 18% year‑over‑year, and revenue of RMB267.5 million ($37.5 M), a 9.6% increase. The results highlight accelerating demand for molecular diagnostics in China.
Exodus Reports Preliminary First Quarter 2026 Results
Exodus Movement reported preliminary Q1 2026 revenue of $22.7 million, a 37% decline from $36.0 million a year earlier. The company launched Exodus Pay nationwide in April, extending its self‑custody platform beyond the core exchange. Processed trading volume fell 22% to $1.18 billion and funded...
Canadian Energy Name Under Pressure After Earnings
Precision Drilling Corp posted first‑quarter revenue of $526 million, a 6% rise from a year earlier, but net earnings slumped to $17.4 million, or $1.34 per share, well below the $2.71 consensus. The earnings miss was driven by a surge in share‑based...
ARCHIMED to Acquire Esperion Therapeutics in a $1.1 Billion Deal
ARCHIMED has agreed to acquire Esperion Therapeutics for approximately $1.1 billion, offering shareholders $3.16 in cash per share—a 58% premium—and a contingent value right (CVR) that could add up to $100 million based on future sales milestones. The transaction values Esperion at...
Seaport, Hemab Price IPOs, While Avalyn Soars in Nasdaq Debut
Three biotech companies priced their initial public offerings between Thursday and Friday, collectively raising more than $850 million. Seaport Therapeutics secured $225 million at $20 per share, while Hemab Therapeutics attracted $210 million at $18 per share. Avalyn Pharma led the pack with...
Interim Data Hint Weaker PFS; Selloff Caps Losses
Leerink's Daina Graybosch on $SMMT "... In our base case scenario of the company’s likely statistical design choices and enrollment timing, not hitting statistical significance at this interim suggests a degradation in PFS Hazard Ratio (HR) of ~10 percentage points...
Fulgent Reports First Quarter 2026 Financial Results
Fulgent Genetics reported first‑quarter 2026 revenue of $71.1 million, a 2.7% decline year‑over‑year, while posting a GAAP loss of $24.8 million ($0.80 per share) and a non‑GAAP loss of $11.0 million ($0.36 per share). The laboratory services segment delivered solid volume, but higher...
GrafTech Reports First Quarter 2026 Results
GrafTech International reported Q1 2026 net sales of $125 million, up 12% year‑over‑year, driven by a 14% increase in sales volume to 28.1 k MT. Despite higher revenue, the company posted a net loss of $43 million, or $1.66 per share, and adjusted EBITDA...
The IPO Buzz: Hemab Therapeutics (COAG) Prices Upsized IPO at $18 – Top – & Stock Pops
Hemab Therapeutics (COAG) upsized its IPO to 16.75 million shares at the top of its $16‑$18 range, raising roughly $301.5 million and valuing the company at about $795 million. The stock opened at $27 and closed the first trading day at $34, delivering...
Seaport Therapeutics Upsizes IPO, Raises $255 Million at $18 per Share
Boston‑based Seaport Therapeutics priced an upsized IPO of 14.16 million shares at $18 each, pulling in about $255 million in gross proceeds and valuing the company near $912 million. The offering, underwritten by a consortium led by Goldman Sachs and JPMorgan, marks a...
OneSpan's Subscription Revenue Rises to $52.7M, Now 80% of Total Revenue
OneSpan announced that subscription revenue grew 8.2% year over year to $52.7 million, representing 80% of its total $65.9 million revenue for Q1 2026. The company also posted a 14.1% rise in ARR to $192.1 million, while hardware sales continued to decline.
ARK Invest Pours $18 M Into CoreWeave as AI Stock Slides
ARK Investment Management, led by Cathie Wood, purchased 162,306 shares of CoreWeave for roughly $18.2 million on April 28, as the stock fell 5.8% after OpenAI missed internal targets. The move adds to a year‑to‑date ARK investment of at least $80 million, underscoring...
Meridian Q1 2026 Delivers 26
$MRDN Q1 2026! Small cap trading 4x EV/ADJ EBITDA whilst growing topline at 17% and ADJ EBITDA at 26% - Rebranding to Meridian is completed. - Best revenue growth in 4 quarters. - Strong ADJ EBITDA growth of 26%. - Net leverage ratio down...
ASX Runners of the Week: 1414, Pathkey.AI, Eclipse & European Lithium
Australian battery‑tech firm 1414 Degrees saw its share price jump 217% after demonstrating a SiNIL nanoparticle anode that delivers 530 mAh/g—about 50% more capacity than conventional graphite—targeting defence drones. Pathkey.AI rallied 92% on its acquisition of Singapore’s Chipforge, expanding its AI...
9 High-Growth Smallcap Stocks Surged up to 170%; 4 Became Multibaggers
The March 2026 earnings season for BSE small‑cap firms revealed a surge of profit growth, with 45 companies posting more than 50% YoY earnings gains. Nine of these stocks delivered extraordinary share‑price jumps ranging from 50% to 170% within a single...
EUR.AX Poised for Upside if Merger Stalls
This is a bit more speculative than I normally play but I have a med sized position in $EUR.AX (pending merger w/ $CRML). I think there's a pretty decent likelihood the original deal gets bumped (or you see a third party)...
Australian Dairy Nutritionals Targets China Growth After Future Brand Powder Sales Lift
Australian Dairy Nutritionals (ASX: AHF) posted $0.92 million USD revenue for the March quarter, with nutritional powders contributing $0.58 million USD and growing 20% year‑over‑year. Total revenue fell 13% versus the prior period after the company exited its North Brucknell milk and...
Fidelity Launches Four Active‑Enhanced Small‑ and Mid‑Cap ETFs, Expanding $149B ETF Suite
Fidelity Investments rolled out four actively managed, factor‑based small‑ and mid‑cap ETFs, priced at 0.23%–0.28% expense ratios. The launch lifts Fidelity’s ETF count to 81 with $149 billion in assets, reflecting growing advisor demand for active‑ETF solutions.
Avoid New Senseonics Longs Until Post‑Offer Clarity
Senseonics priced $80M at $5 vs $6.61. Strong current ratio & 57% revenue growth but heavy cash burn and EPS miss. Risk: dilution/opex. Trade: avoid new longs until post-offer clarity. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
ROG's Cooling Chip Pivot Sparks Interest Despite Boring Valuation
$ROG is a boring stock that @GeoInvesting started watching a few days ago, due to strong Q1 EPS. It’s not cheap. But the move to explore adapting Co. solutions to “cooling chip” data center solutions is interesting, especially given $NVDA...
Challenger Strengthens Hualilán Toll Milling Case with High-Grade Gold Hits
Challenger Gold reported high‑grade gold and silver intersections from infill drilling at its Hualilán toll‑milling pits in Argentina, with the Magnata pit averaging 7.0 g/t Au, surpassing the 6.2 g/t target in its 2025 PFS. Notable intercepts include 8 m at 16.3 g/t Au...
Bloom $BE: Unmatched Growth Leader in Market
I will reiterate what I said in early 2025, Bloom $BE is the greatest growth story in the entire market and there really is not a close second Just read the latest call, they are firing on all cylinders (but...
AEG Management Undervalues Shares, Angers Investors
Management of #AEG should be very proud for shafting shareholders . Issuing stock at completely the wrong price 😡😡😡
Here Is Why Amrize (AMRZ) Is One of the Best IPO Stocks to Buy in 2026
Amrize (NYSE:AMRZ) announced a strategic expansion of its ‘Made in America’ label to four additional U.S. cement plants, bringing the total to nine sites. The company is committing $900 million in 2026 capital expenditures to boost capacity at its flagship Missouri...
World Acceptance Corporation (WRLD): Deep Value Consumer Lending Business
World Acceptance Corp. (WRLD) is a branch‑based consumer finance firm serving non‑prime borrowers in the U.S. and Mexico with small‑dollar installment loans, tax services and credit insurance. The company reports $525.5 M revenue, $42.8 M net income and $252 M free cash flow...
Bison Resources Targets Carlin Trend Discoveries After Impressive ASX Debut
Bison Resources (ASX: BSR) debuted on the Australian Securities Exchange on April 16, raising an oversubscribed $5.5 million IPO. The proceeds will finance a multi‑stage exploration campaign across four Nevada projects—Ruby Lake, Cherry Springs, Bald Peaks and Medicine Range—situated in the...
Stride Posts 1.8% Enrollment Rise, Revenue up 2.7% in Q3 2026
Stride, the online K‑12 provider, announced total enrollments of 244,500 in the third quarter, a 1.8% rise year‑over‑year, while revenue climbed 2.7% to $629.9 million. The results underscore continued demand for digital schooling despite tighter enrollment windows and a modest dip...
Genie Energy Ltd (GNE) Q4 2025 Earnings Call Transcript
Genie Energy reported a 24% rise in consolidated revenue to $138.3 million, driven by strong electricity sales and higher per‑meter consumption. Gross profit fell 21% as wholesale commodity costs compressed margins, with gross margin dropping to 21.7% from 33.9% a year...
Gates Industrial Corporation PLC (GTES) Q1 2026 Earnings Call Transcript
Gates Industrial reported Q1 2026 revenue of $851 million, a 2.9% core sales decline driven by an ERP transition and two fewer working days. Adjusted EBITDA fell to $177 million with a 20.8% margin, down 130 basis points, while adjusted...
GrafTech International Ltd (EAF) Q1 2026 Earnings Call Transcript
GrafTech International reported a 6% rise in full‑year sales volume, driven by a 48% surge in U.S. shipments, while average selling price fell 9% to roughly $4,000 per metric ton. The company achieved an 11% reduction in cash cost to...
Upland Software Inc (UPLD) Q1 2026 Earnings Call Transcript
Upland Software reported flat Q4 organic growth but improved profitability, delivering $15.3 million adjusted EBITDA at a 31% margin, up from 22% a year earlier. Free cash flow reached $24.4 million, surpassing its $20 million target, while net dollar retention...
Sabra CEO: Skilled Nursing Deal Flow Tight Amid Fierce Competition From OpCo and PropCo Private Buyers
Sabra Health Care REIT is pivoting away from skilled‑nursing assets toward its Seniors Housing Operating Portfolio (SHOP), with private‑pay revenue now representing over 50% of the portfolio for the first time. The CEO said skilled‑nursing deal flow remains tight as...